Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort

Authors:

Abstract
No abstract available
Funding Information
  • NHMRC
  • National Breast Cancer Foundation
  • Australian Government Department of Industry Innovation and Science
  • National Breast Cancer Foundation

This publication has 25 references indexed in Scilit: